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Abstract
Background: Therapeutic hypothermia is neuroprotective in asphyxiated neonates by counteracting mechanisms
contributing to brain injury. Although an initial increased permeability is part of an inflammatory reaction and
thereby a natural healing process, an excessive endothelial permeability with edema formation may result in
impaired hemodynamics. Reduced permeability may, however, benefit healing. Although plasma and interstitial
colloid osmotic pressure are accessible and essential parameters for understanding fluid imbalance, the
mechanisms of fluid exchange remain poorly understood. The potential influence of therapeutic hypothermia on
plasma and interstitial colloid osmotic pressure, and the relationship between inflammatory markers and colloid
osmotic pressure in asphyxiated neonates, was investigated.
Methods: Seventeen neonates with moderate to severe hypoxic ischemic encephalopathy, born after 35 weeks
gestation, received servo-controlled whole body cooling before 6 h of age, followed by gradual rewarming after
72 h. All infants were treated according to a national hypothermia protocol. Interstitial fluid in the skin was
collected at 7, 13, 25, 49, and 73 h after birth by subcutaneous implantation of multifilamentous nylon wicks with
60 min of implantation time. Biomarkers of inflammation and colloid osmotic pressure were measured in serum
and interstitial fluid.
Results: A modest decrease in serum and interstitial colloid osmotic pressure was measured, leaving an unaltered
difference in colloid osmotic pressure gradient. A decline in mean arterial pressure was observed between 7 and
13 h of life, with a concomitant decrease in positive fluid balance within the same time frame. White blood cell
count and leukocyte subclasses dropped significantly throughout treatment, with elevated interstitial interleukin
(IL)-1α and decreased serum IL-1RA, IL-6, and IL-10 during treatment time points.
Conclusions: Colloid osmotic pressures measured in serum and interstitial fluid during asphyxia is lower than
previously reported, with small alteration of pressure differences across capillaries, reducing vascular filtration. An
inherent local and systemic regulation of inflammation together with changes in colloid osmotic pressure may
indicate a possible preventive mechanism of edema generation during neonatal asphyxia and therapeutic
hypothermia.
Trial registration: ClinicalTrials.gov Identifier: NCT01044940. Date of registration: January 8, 2010.
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Background
Hypoxic ischemic encephalopathy (HIE) due to perinatal
asphyxia is an important cause of childhood neurodevelop-
mental deficits that include loss of motor and cognitive
functions [1, 2]. Hypoxic ischemia could be involved in the
injuries correlating with HIE by initiating a detrimental in-
flammatory response, partly through the release of reactive
oxygen species and amplified by inflammatory cytokines.
Several clinical studies and reports from experimental
models have shown that immune pathogenic mechanisms
may play an essential role in HIE by affecting both the
central nervous system and systemic circulation [3–6].
Therapeutic hypothermia (TH) induces an artificial reduc-
tion of core and brain temperature to 33.5 °C. This results
in reduced cerebral and whole-body metabolism, followed
by attenuation of oxidative stress after hypoxemia [7].
Several studies have shown that TH also provides neuro-
protection in neonates with moderate to severe HIE [8, 9],
potentially through favorable effects on multiple pathways
contributing to brain injury. Thus, TH has been demon-
strated to induce an anti-inflammatory response with re-
duced amounts of circulating leukocytes and chemokines
in neonates with HIE, as well as in animal models [5, 10].
This inhibiting effect of the immune system in response to
TH may be protective against the over-functioning immune
reaction observed in these children [11]. Moreover,
hypothermia has been shown to have beneficial effects on
capillary integrity, as evidenced by reduced accumulation of
interstitial fluid (IF) through decreased endothelial perme-
ability, in rats after hemorrhagic shock [12]. However,
increased intravascular hydrostatic pressure, due to TH-
induced peripheral vasoconstriction, along with reduced
venous return [13], could theoretically result in interstitial
accumulation of fluid. Few studies have addressed these
mechanisms of fluid imbalance during TH in neonates, and
cytokine concentrations in the cellular microenvironment
have not been previously measured. Because plasma colloid
osmotic pressure (COPp) and interstitial colloid osmotic
pressure (COPi) are essential determinants of fluid ex-
change during edema formation [14], we herein examined
whether TH influenced these parameters in neonates with
HIE, expecting a reduced COPp as reported in sick neo-
nates [15]. We also explored the association between COPp
and COPi and inflammatory processes during TH by meas-
uring a wide panel of cytokines in the plasma and IF.
Methods
Ethics
The study was approved by the Regional Committees for
Medical and Health Research Ethics, Western Norway, and
was conducted at the Neonatal Intensive Care Unit (NICU),
Haukeland University Hospital, Bergen, Norway. All patients
were included in the study following written informed con-
sent obtained from a parent or guardian after explanation of
the study in accordance with the Declaration of Helsinki.
The study trial was registered in ClinicalTrials.gov (Clinical-
Trials.gov Identifier: NCT01044940).
Study population
The study was an open, longitudinal, observational study,
taking place between June 2009 and October 2014.
Newborns treated with TH owing to moderate and severe
HIE were included after fulfillment of national inclusion
criteria for neonatal TH. Inclusion and exclusion criteria
are presented in Table 1.
Clinical management
All recruited patients were, as part of the clinical routine,
sedated with morphine or fentanyl and intubated after de-
livery or before transport from referring hospitals at the
attending physicians discretion. Rectal temperature was
continuously monitored, with a target body temperature
between 34 and 36 °C before TH. All patients received
prophylactic antibiotics (penicillin and gentamycin)
throughout TH, and scheduled clinical and biochemical
monitoring was performed by the attending physician
discretion.
Neonatal TH protocol
TH was conducted according to the hospital hypothermia
protocol. Induction and maintenance of hypothermia was
achieved by servo-controlled whole body cooling equip-
ment (Criticool; Mtre, Yavne, Israel) and the core
Table 1 Criteria for inclusion of therapeutic hypothermia
Inclusion criteria Exclusion Criteria
A: Gestational age ≥ 36 weeks Expected need for surgical
treatment (before 3 days
of age)
B: At least one of the following: Severe birth defects with
expected poor prognosis
1. Apgar score ≤ 5 at 10 min after
birth
2. Requires positive pressure
ventilation 10 min after birth
3. pH < 7.00 in umbilical arterial
blood or arterial blood within
60 min after birth
4. Base excess ≤ − 16 in umbilical
arterial blood or arterial blood
within 60 min after birth
C: Signs of moderate to severe
encephalopathy with at least
one of the following:
Age > 6 h before hypothermia
could be initiated
1. Hypotonia
2. Abnormal reflexes or constricted/
deviated, dilated, nonreactive to
light pupils
3. Weak or absent sucking reflex
4. Presence of seizures
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temperature was reduced to 33.5 °C before 6 h of age and
maintained until 72 h after birth. The rectal temperature
was not allowed to increase more than 0.3 °C per hour
during rewarming. After rewarming, rectal temperature
was monitored for 24 h to prevent rebound hyperthermia.
Patients with the expected poorest prognosis (in extremis)
underwent magnetic resonance imaging (MRI) during
cooling (second or third day of TH). Otherwise, imaging
took place at day 4 to 7. Cerebral ultrasound was con-
ducted during the first 3 days and before discharge.
Intensive care monitoring and treatment
Patients were treated in an open-radiant infant
warmer incubator (Dräger Babytherm 8010, Dräger
Medical, Lübeck, Germany) with the heating blanket
and radiant warmer turned off. TH data were re-
corded according to local protocols and monitoring
was performed (Intellivue MP70 Neonatal, Philips, Eidhoven,
Nederland) with continuous arterial pressure, oxygen satur-
ation, heart rate, and respiration registration. All patients
were monitored with an amplitude-integrated electroenceph-
alogram to assess cerebral function within 3–6 h after TH
initiation. From January 2011 onward, ventilation therapy
was provided by Dräger Babylog® VN500 (Dräger Medical,
Lübeck, Germany) with the pressure- and assist-controlled,
volume-guaranty mode. Prior to 2011, the Stephanie Neo-
natal and Paediatric ventilator (Stephan, Gackenback,
Germany) was utilized, with the pressure-controlled synchro-
nized intermittent mandatory ventilation mode. Morphine
sedation was administered throughout treatment if the pa-
tient showed signs of improvement during TH. Otherwise, if
expected poor prognosis, sedation was halted and early MRI
was performed. All neonates received the recom-
mended reduced fluid intake [16] of approximately
40 ml/kg/day adjusted to weight, urine output, and
serum sodium levels. Intravenously administered
fluids consisted of isotonic saline (NaCl 9 mg/ml), glu-
cose (concentration range of 100 mg/ml to 300 mg/ml,
adjusted to a calculated need of 6 mg/kg/min), and blood
products according to the patients’ requirements.
Enteral feeding was not established during TH. The
calculation of fluid balance was based on the total
amount of fluid intravenously administered and mea-
surements of hourly diuresis (urinary catheter) and
gastric aspiration. Daily weight was not measured due
to attached technical equipment, and fluid loss from
respiratory evaporation or obvious fluid accumulation
during TH was deemed not feasible due to the
clinical setting. If the mean arterial pressure (MAP)
was < 40 mmHg, and a fluid load of 9 mg/ml NaCl
(10–20 ml/kg) proved ineffective, dopamine was ad-
ministered. In the case of no clinical improvement,
treatment was followed by adrenaline. Seizures during
TH were treated with phenobarbital/phenytoin, and
hypothermia was prolonged if the seizures appeared
during rewarming.
Sampling of interstitial fluid and blood
Sterile, nylon, multifilament wicks soaked in 9 mg/ml
NaCl were subcutaneously implanted 4 cm in length
into either the arm or the leg for 60 min in accordance
with previous studies [14, 17]. The wicks were implanted
at 6, 12, 24, 48, and 72 h after birth. Retracted wicks
were placed into 1.5-ml Eppendorf centrifuge tubes with
funnel (Sarstedt, Nümbrecht, Germany) containing min-
eral oil. Following centrifugation of the wicks, IF was ex-
tracted and frozen at − 20 °C for later analysis. Colloid
osmotic pressure (COP) was measured using a colloid
osmometer designed for small samples [18] equipped
with a membrane impermeable for molecules > 30 kDa
(PM-30, Amicron, Lexington, MA, USA). COP was
amplified and recorded with Easy Graph P930 (Gould
Inc., Ohio, USA). Blood samples were collected from an
arterial line both before installation and retraction of the
wick. The blood samples were allowed to clot and serum
was subsequently isolated, frozen at − 20 °C. COP deter-
mined from either plasma or serum is equivalent [19],
and patient serum, a surrogate for patient circulating
plasma, was later analyzed in the above-mentioned
colloid osmometer and is denoted in the manuscript as
COPp. Additional blood analyses, such as serum albumin
and hemoglobin concentrations, were performed at the
Laboratory of Clinical Biochemistry at Haukeland
University Hospital. The concentrations of 15 cytokines
were analyzed in serum and IF using a multiplex bead im-
munoassay (Milliplex HCYTMAG-60; Merck Millipore,
Darmstadt, Germany): interferon gamma, interleukin (IL)-
1α, IL-1β, interleukin-1 receptor antagonist (IL-1RA), IL-2,
IL-6, IL-8, IL-10, IL-12p40, monocyte chemoattractant pro-
tein-1, macrophage inflammatory protein-1α, transforming
growth factor-α, tumor necrosis factor (TNF)-α, TNF-β, and
vascular endothelial growth factor. The procedure was
performed as recommended by the manufacturer,
measured in a 1:12.5 dilution, and analyzed, with a
Luminex 100™ instrument (Luminex Corp.; Austin,
USA) and StarStation software (Applied Cytometry Systems;
Dinnington, UK) at the Broegelmann Research Laboratory,
Department of Clinical Sciences, University of Bergen,
Norway. Values were reported as picograms per milli-
liter (pg/ml). Because of scarce amounts of material,
we were not able to verify cytokine results by running
the tests in parallel.
Statistical analysis
Data and analysis were evaluated using SigmaStat 11 (Sy
Stat Software Inc.; California, USA). One-way analysis of
variance was used to evaluate COPp, COPi, cytokines,
MAP and fluid balance between different treatment time
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points. If there was a significant difference between the
mean values of the groups, an all pairwise multiple com-
parison procedure (Holm-Sidak or Dunn’s methods) was
used to isolate the specific groups. Nonparametric tests
for correlation calculations of continuous variables were
performed by Spearman’s rank correlation test, and cat-
egorical variables were analyzed by the Mann–Whitney
U-test. Continuous variables are expressed as mean ±
SD, and categorical variables are expressed as counts




Twenty-nine neonates had moderate to severe HIE and
were treated with hypothermia in the NICU during the
study period. Seventeen of these patients (58%), 8 (47%)
female, were included in the study. Twelve neonates
could not be included due to lack of study personnel
available for implanting wicks. A total of 13 out of 17
participating infants survived after 3 days of TH, and
one infant developed necrotizing enterocolitis (NEC). One
non-survivor had a congenital diaphragmatic hernia. The
included patients did not have known septicemia,
genetic or neuromuscular abnormalities and were not
influenced by maternal chorioamnionitis. No patients
were clinically characterized as edematous throughout
TH. Gestational age (GA) varied from 35+ 4 to 42+ 3
weeks (mean GA of 39+ 6 weeks eq. 279 days), and
average weight was 3464 g (range 2483–4710 g). One
patient received TH despite having a GA below
36 weeks. There were no sex-related responses in in-
cluded patients, and additional clinical characteristics
are presented in Table 2.
Fluid calculations, hemodynamic and laboratory variables
during TH
Seven patients received inotropic support with dopa-
mine as the primary vasopressor. MAP demonstrated
a significant drop (P < 0.05) from 47.3 ± 6.9 mmHg
at 7 h to 42.9 ± 8.2 mmHg at 25 h of life, but in-
creased to 50.7 ± 5.3 when rewarming was initiated.
A positive fluid balance of 4.1 ± 2.4 ml/kg/h 7 h after
birth decreased significantly (P < 0.001) to 1.6 ±
1.9 ml/kg/h 13 h after birth and declined further to
1.0 ± 1.0 ml/kg/h until TH was completed. Urine
output increased fourfold (P < 0.05) and nearly
sevenfold (P < 0.05) from 7 to 25 and 73 h after birth
(0.19 ml/kg/h to 0.85 ml/kg/h and 1.28 ml/kg/h respect-
ively). Following TH, hemoglobin levels also decreased to-
gether with a transient decline in serum sodium levels
between 7 and 25 h, whereas potassium and creatin-
ine levels remained stable throughout the period.
Serum glucose levels were reduced to approximately
50% during the first 24 h after birth. Albumin
remained within the reference range [20], although
levels significantly declined from 29 g/l to 26 g/l
(P < 0.05) from the first 24 h to the 25–97-h period.
Laboratory variables during TH and the first 24 h of
rewarming are presented in Table 3.
Effect of TH on inflammatory markers
C-reactive protein showed a marginal increase from 16 mg/
l to 24 mg/l between 49 and 73 h after birth (Table 3).
Circulating total white blood cells (WBC) decreased signifi-
cantly within the time points (7, 13, 25, 49, 73, and 97 h), as
well as leukocyte subclasses, such as neutrophils, lympho-
cytes, and monocytes. There was a minor decline in the
number of thrombocytes throughout TH (defined by plate-
let count < 150 × 109/l).
Effect of TH on COP
An initial power-sample size evaluation based on n = (2 *
(SD/delta))2*k calculated n = 13 if a change in COPp of
2.5 mmHg with 90% test strength and 5% level of signifi-
cance was to be achieved. Similarly, a COPp change of
1 mmHg or 2 mmHg need n = 40 and 20 respectively.
Therefore, n between 12 and 20 should be adequate to
detect a 2–2.5 mmHg change of COPp.
A total of 22/68 wicks (32%) were discarded owing to
blood contamination. Mean wick implantation time was
61 min. Mean COPp and COPi during TH were 14.5 ±
2.6 mmHg and 8.9 ± 1.9 mmHg, respectively. For COPp,
we observed a decrease from 15.6 ± 1.9 mmHg at 7 h
after birth to 13.8 ± 2.4 mmHg at 49 h of life, followed
by a modest increase to 14.5 ± 2.6 mmHg at 73 h. For
COPi, there was a small decline throughout TH from
9.2 ± 0.8 mmHg at 7 h to 7.8 ± 1.7 mmHg at 73 h (Fig. 1).
However, none of the changes in COPp or COPi during
TH were significant (P = 0.12 and 0.954, respectively).
Table 2 Study group characteristics of enrolled patients
Characteristics N = 17
Gender: male, n (%) 9 (53)
Apgar score at 1 min, mean (range) 1 (0–5)
Apgar score at 5 min, mean (range) 2 (0–6)
Apgar score at 10 min, mean (range) 2 (0–6)
PROM, n (%) 3 (18)
Delivery mode, n (%)
Emergency cesarean 9 (53)
Vaginal 8 (47)
SGA, n (%) 4 (26)
Seizures, requires anticonvulsant drug, n (%) 7 (41)
Referred from other hospitals, n (%) 6 (35)
PROM Premature rupture of membranes > 24 h, SGA Small for gestational age,
indicates birth weight below 10th percentile for gestational age
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The pressure gradient, ΔCOP, between plasma and inter-
stitium remained unchanged, although there was a ten-
dency to increase during TH.
Effect of TH on IF and serum levels of growth factors,
cytokines, and chemokines
In contrast to the minimal changes in COP, there were
several alterations in levels of inflammatory mediators
during TH. Compared with the measured values at 7 h,
the serum IL-1RA levels significantly decreased between
49 and 73 h (P < 0.05). IL-6 levels were significantly de-
creased at 73 compared with levels at 7 h (P < 0.05), and
IL-10 levels were significantly decreased at 25, 49, and
73 h compared with levels at 7 h (P < 0.05). The changes
in these IF inflammatory parameters were very different
from what we observed in the serum levels. IL-1α was
the only IF cytokine with a significant (P < 0.05) increase
throughout TH, with a rapid rise after 49 h. Conversely,
IL-1RA levels were significantly decreased after 7 and
25 h of TH (P < 0.05). Additionally, higher serum IL-6
and IL-8 levels, compared with IF, were observed
throughout TH. Changes in the remaining cytokine
levels were small and non-significant. The mean levels
of measurable cytokine concentrations in IF and serum
at various time points during TH are presented in
Table 4 and selected cytokines in Fig. 2.
Correlations between changes in IF and serum cytokine
levels, and clinical and imaging parameters
We found a significant correlation between decreased
MAP and increased IL-1α in the IF between 7 and 49 h,
and a non-correlating rapid rise in interstitial IL-1α and
elevated MAP from 49 to 73 h. We also observed signifi-
cant negative correlations between IF IL-1α levels at 7 h
and later measurements of COPp (12, 24, and 72 h) and
COPi (48 h). Additionally, the IF IL-1α levels at 13 and
25 h were associated with COPp at 73 h. Although
serum levels of IL-1RA and IL-10 significantly decreased
during TH, there were no significant correlations with
MAP, COPp, COPi, or fluid balance for these cytokines.
For all other cytokines, there was no association with
MAP, COPp, COPi, or fluid balance, as well as no corre-
lations between cytokine levels and clinical variables.
Discussion
In the present study, HIE neonates were treated with TH
and experienced a reduced COPp similar to previously
reported in asphyxiated newborns [21]. The interstitial
COP from TH treated neonates was nearly halved com-
pared to previous reports from healthy children [14],
and during TH a non-significant decrease was found in
both COPp and COPi throughout the various treatment
time points. In the IF, the pro-inflammatory IL-1α
showed increased levels during hypothermic treatment,
which coincided with decreased total WBC count and
no clinical or laboratory signs of edema formation.
Neonates that experience scarce spontaneous ventila-
tion, inadequate heart rates, and low Apgar scores at 1–5
and 10 min after birth are often resuscitated and in need
of intensive care treatment. In addition to respiratory
support, great care is taken to regulate circulatory homeo-
stasis with adequate intravascular volume and efficient
organ perfusion. Although a clinician may control the vol-
ume of administered fluid, the ability to dictate its path-
ways is challenging owing to deviation in blood pressure,
circulating blood volume, interstitial accumulation of fluid
and capillary permeability. Among the forces that alter
passage of fluid from blood vessels to the interstitium,
COPp and COPi are most easily examined in the plasma
(equal to serum) and by extracting IF from subcutaneously
implanted wicks. The endothelial glycocalyx, a multicom-
ponent luminal network of membrane bound proteogly-
cans and glycoproteins covering the endothelial cells,
creates a COP gradient close to the barrier of filtration.
COPi, a marker of glycocalyx COP (COPg), works close to
the endothelium border and is thought to mirror COPg
under normal filtration rates [22]. COPp in healthy adults
(25 mmHg) [17, 23] is reported equal to children [14] but
higher than in term [24]- and pre-term neonates [15]
(20 mmHg and 15 mmHg, respectively). Sick neonates, re-
gardless of maturity, have an even more decreased COPp
[15, 24, 25]. Sussmane et al. showed that COPp in healthy
infants from 1 to 11 months is in proportion to adult
values, with an anticipated COPp increase during the first
month of life [26]. Throughout TH treatment in the
present study, the mean COPp (14.3 ± 2.6 mmHg) coin-
cides with earlier observations of lowered plasma COP in
sick newborns [15]. Although there were no significant
changes in COP in serum during TH, the decline in COPp
Fig. 1 Colloid osmotic pressure and therapeutic hypothermia.
Measured colloid osmotic pressure in serum (○) and interstitial fluid
(●) plotted against duration of therapeutic hypothermia
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during the first 13 h was most likely due to simple dilution
of plasma proteins. A possible explanation is the initial
treatment with intravenous fluid resuscitation and subse-
quent stabilization in the NICU. The following fluid re-
striction will result in a more constant COPp (Fig. 1).
These results correspond with the significantly increased
positive fluid balance during the first 7 h after birth com-
pared with the remaining TH period (P < 0.01) and a tran-
sient hyponatremia of 126 mmol/l serum sodium at 13 h
after birth. Skin vasoconstriction due to whole body cool-
ing, as well as reduced urine output, elevated serum cre-
atinine, and mechanical ventilation, are potential reasons
for excess fluid. Such fluid accumulation occurred des-
pite our adherence to the recommended reduced daily
fluid intake. More novel is the finding of a reduced
COPi of 8.9 ± 1.9 mmHg compared with COPi from
children between 2 and 10 years (13.9 ± 3.5 mmHg)
[14], and a corresponding ΔCOP (i.e., COPp – COPi)
nearly constant during TH. A relatively balanced COP
gradient together with a reduced serum albumin, sug-
gests that other plasma proteins compensate in main-
taining COPp since the patients were only, to a small
extent, administered crystalloids and blood products.
Unfortunately, there was not enough material to
measure total protein and albumin concentration in
the IF owing to protocol restrictions. The significant
decline (P < 0.05) in serum albumin from 29 to 26 g/l
with stable COPp between the first day and the last
2 days of TH may indicate capillary hyperpermeability
propelled by the asphyxia event inducing an inflam-
matory cascade [11]. Other macromolecules that re-
place plasma albumin or reduced circulatory fluid
would maintain an unaltered COPp. Conversely, reduced
liver function with less synthesized albumin and restricted
fluid access would produce a similar situation.
The present results showing albumin within the refer-
ence range, although reduced during TH, may be due to
a reduced inflammatory stimulus as a result of
hypothermia [27] or increased lymphatic fluid removal,
although the latter was shown to be less likely in sedated
and immobilized dogs [28].
According to the Starling equation, increased capillary
filtration coefficient (CFC) (proportional to hydraulic
conductivity (Lp) and the capillary area accessible for
fluid shift) and/or elevated capillary hydrostatic pressure
(Pc), as well as a decline in the reflection coefficient (σ),
may increase fluid extravasation. Capillary pressure is
dependent on arterial pressure and venous pressure,
together with pre- and post-capillary resistance [29].
Michel et al. demonstrated increased permeability due
to elevated Lp after mild thermal injury, which expressed
a biphasic course and diminished after several hours
[30], whereas Lundblad et al. showed that endotoxemia
in cat skeletal muscle resulted in reduced σ and signifi-
cantly increased CFC [31]. Whether asphyxia and inflam-
mation stimulates changes triggering barrier disruption
owing to altered Lp or σ is uncertain, as well as how TH
affects these parameters.
MAP, which decreased during the first 25 h of TH, is
dependent on peripheral resistance and cardiac output,
the latter known to be reduced during asphyxia and TH
[32]. Consequently, an expected increased peripheral re-
sistance, primarily post-capillary, takes place after TH
initiation and results in increased Pc (given unaltered
CFC and σ), thereby forcing extravasation to the intersti-
tium. A small, but detectable, fall in COPi compared
with COPp is maintained by removal of albumin or other
proteins comparable in size from the interstitium. The
reduced COPi and COPp during TH in asphyxiated
neonates and the ability of TH to oppose changes in
capillary filtration by COP in IF is an edema preventive
mechanism demonstrated in animal [33] and human
[34] studies.
Two thirds of patients in the present study developed
mild thrombocytopenia, which is associated with birth
asphyxia [35] as well as TH activation and aggregation
of platelets with potential thrombus formation [13]. The
reduced platelet count as a result of hypothermia is
Fig. 2 Cytokines and neonatal asphyxia. Median cytokines levels over time in serum (○) and interstitial fluid (●) during therapeutic hypothermia.
X-axis refers to hours after initiation of therapeutic hypothermia, y-axis refers to concentration, pg/ml. a, Interleukin (IL)-1α b, IL-6. c, IL-10 (IF IL-10
not detectable)
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thought to be protective from microvascular slugging
and related to increased blood viscosity and vasocon-
striction; the patients in the present study exhibited no
vascular incidents, with exception of one patient who re-
quired platelet transfusion and surgery owing to NEC
during TH.
Results from the present study showed decreased
levels of IL-6, a pleotropic cytokine, in IF compared with
serum, which could be due to negligible tissue damage
and subsequent inflammation; this supports the validity
of the wick technique as a less traumatic method for
sampling of IF. A significant reduction in WBC count
with neutropenia was also observed along with a delayed
initiation of CRP response. This was in accordance with
recent observations of non-sepsis-risk neonates treated
with TH [36]. Leukopenia with reduced IL-10 is associ-
ated with better outcome in animal models of brain in-
jury and in human adult stroke patients; the observed
functional immune compromise may be due to bone
marrow suppression and reduced leucocyte release [10].
Conversely, a prolonged leukopenia that does not re-
cover after rewarming, as we observed, is associated with
a poor prognosis at 12 months [37], although treatment
outcome was beyond the scope of this trial to measure.
Endothelial dysfunction is associated with perinatal as-
phyxia [38], and the concomitant acute inflammation
from ischemia-reperfusion injury triggers a compulsory
formation of intracellular gaps owing to activation of the
actin-myosin system with increased permeability. To the
best of our knowledge, increased levels of IL-1α in IF from
skin, which suggests local cytokine production, has never
been measured in neonates. The finding of an amplified
IL-1α in the IF throughout TH treatment, suggests an up-
regulation from keratinocytes and other cells in the subcu-
tis [39]. Whether IL-1RA, which decreased during the first
49 h of TH, antagonized IL-1α initially is uncertain. Al-
though recombinant IL-1α injected intravenously into
rabbits exerts a rise in temperature [39], it remains un-
clear whether the increased IL-1α in IF was due to
asphyxia or potentiated by the hypothermic environment.
The correlation between increased IL-1α and decreased
MAP was not obvious, although TH-increased post-capillary
resistance may be influenced by inflammation-affected endo-
thelium and the resulting increased extravasation resulting in
a lowered COPi. Mild hypothermia can be demonstrated by
a lowered secretion of IL-10 in cell culture [40], as well as by
interleukin expression in hypothermic neonates, although
levels are initially higher during TH [37]. This was in line
with the findings from the present study. The anti-
inflammatory effects of TH on the vascular endothelium
remain uncertain and not well studied, although a recent
report showed better outcomes in neonates treated with
shortened TH for 49 h, as well as down-regulation of serum
IL-6, IL-8, and IL-10 [37].
The present study has some limitations. The most
important of these limitations is that an unusually
high number of wicks had to be discarded due to
blood contamination, thus limiting the aggregate of
measurements with each time-period during TH and
thereby the power of the analysis at some data points.
Unusable wicks represented nearly 50% of extracted
wicks at 7 and 73 h after birth. Time from birth to
initiation of TH was not identical within the group
and may have influenced the relationship between
biological parameters and time periods of TH,
although less likely since body temperature were kept
between 34 and 36 °C after initial stabilization. Also,
the results presented are limited to the experience of
one tertiary NICU and may not be generalizable. The
osmolality of fluids intravenously administered during
TH was not calculated, although it is less likely that
crystalloids have a major impact on intravascular ton-
icity. Daily weight was not measured owing to the at-
tached technical equipment. Therefore, potential fluid
loss from respiratory evaporation or obvious fluid
accumulation during TH was undetected. The clinical
evaluation of edematous skin, together with fluid cal-
culations and measurements of vascular tonicity, was
performed by the attending physician and variations
in fluid treatment may have occurred. Furthermore,
the degree of asphyxia is difficult to interpret with al-
tered physiology in response to both hypoxic ischemia
and TH.
Conclusions
Neonates treated with TH have a decreased, but stable,
COPp and a compensatory low COPi. This results in reduced
vascular filtration with a COP gradient counteracting fluid
flux from the capillaries to the interstitium, which likely
functions as an edema-preventing mechanism. The decrease
in MAP and reduced positive fluid balance during the first
24 h of TH, as well as no observed clinical edema, supports
this assumption. Furthermore, hypothermia induces an ex-
pected low WBC and platelet count in neonates without any
risk factors for infection. This is likely part of an inherent as-
phyxia protection system together with a fairly balanced local
and systemic cytokine production. The results presented in
this study provide novel and valuable information concern-
ing tissue cytokine production during TH.
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